— Know what they know.
Not Investment Advice

LVVV OTC

LiveWire Ergogenics, Inc.
1W: +0.0% 1M: -25.0% 3M: -25.0% YTD: -50.0% 1Y: -0.0% 3Y: -91.3% 5Y: -98.5%
$0.00
+0.00 (+0.00%)
 
Weekly Expected Move ±12.5%
$0 $0 $0 $0 $0
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 49 · $571194 mcap · 19M float · 3.79% daily turnover · Short 37% of daily vol

Income Trends

Revenue
$8K -97.4% ▼
5Y CAGR: -57.7%
Gross Profit
-$17K -106.1% ▼
Operating Income
-$182K -252.8% ▼
Net Income
-$5M -6176.6% ▼
EPS (Diluted)
$-0.00 +0.0% ▲
EBITDA
-$157K -148.8% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$851K$2M$2M$304K$8K
YoY Growth+46.7%+127.7%-15.7%-81.4%-97.4%
Cost of Revenue$150K$133K$39K$19K$25K
Gross Profit$702K$2M$2M$285K-$17K
Gross Margin82.4%93.1%97.6%93.8%-222.6%
R&D Expenses$0$0$0$0$0
SG&A Expenses$3M$1M$764K$166K$165K
Operating Expenses$3M$1M$764K$166K$165K
Operating Income-$2M$645K$830K$119K-$182K
Operating Margin-292.5%33.3%50.8%39.3%-2328.5%
Interest Expense$605K$249K$245K$224K$356K
Income Before Tax-$3M$684K$922K$79K-$62K
Tax Expense$0$0$0$0$0
Net Income-$3M$684K$922K$79K-$5M
Net Margin-403.2%35.3%56.4%25.9%-61057.3%
EPS (Diluted)$-0.00$0.00$0.00$0.00$-0.00
EBITDA-$3M$1M$1M$322K-$157K
Shares Outstanding1.58B1.88B1.94B1.88B1.88B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms